
Impact of utilization of hepatitis C positive organs in liver transplant: Analysis of united network for organ sharing database
Author(s) -
Amaninder Dhaliwal,
Banreet Dhindsa,
Daryl Ramai,
Harlan Sayles,
Saurabh Chandan,
Rajani Rangray
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i5.984
Subject(s) - medicine , united network for organ sharing , hepatitis c , hepatitis c virus , log rank test , gastroenterology , group a , group b , survival analysis , immunology , liver transplantation , transplantation , virus
The utility of hepatitis C virus (HCV) organs has increased after the Food and Drug Administration approval of direct acting anti-viral (DAA) medications for the HCV treatment. The efficacy of DAA in treating HCV is nearly 100%.